Published in Pol Arch Med Wewn on October 01, 1972
Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation. Heart (2007) 1.85
Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol (1999) 1.65
Successful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet (1979) 1.57
Humoral immunosuppression in men exposed to polycyclic aromatic hydrocarbons and related carcinogens in polluted environments. Environ Health Perspect (1994) 1.49
Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension. Br Heart J (1978) 1.15
Haemodynamic changes induced by prostacyclin in man. Br Heart J (1980) 1.11
Prostacyclin for pulmonary hypertension. Lancet (1980) 0.98
Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Heart (2000) 0.96
Technetium 99m stannous pyrophosphate myocardial imaging in patients with and without left ventricular aneurysm. Circulation (1976) 0.93
The noninvasive cardiac evaluation of long-distance runners. Chest (1978) 0.92
Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (2000) 0.92
Silent myocardial ischaemia in Holter monitoring and exercise stress testing after a first myocardial infarction. Eur Heart J (1988) 0.86
Verapamil normalizes the response of left ventricular early diastolic filling to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (1997) 0.85
Limited clinical diagnostic specificity of technetium-99m stannous pyrophosphate myocardial imaging in acute myocardial infarction. Am J Cardiol (1977) 0.85
Impaired response of the forearm resistance but not conductance vessels to reactive hyperemia in hypertrophic cardiomyopathy. Angiology (1999) 0.84
Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy. Heart Vessels (1996) 0.84
Prostacyclin for acute coronary insufficiency. Artery (1980) 0.83
Cold pressor thallium-201 myocardial scintigraphy in the diagnosis of coronary artery disease. Am J Cardiol (1982) 0.82
Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy. Heart (2005) 0.82
Determinants of depressed left ventricular ejection fraction in pure mitral stenosis with preserved sinus rhythm. J Heart Valve Dis (1996) 0.81
Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy. Int J Cardiol (2004) 0.80
Prostacyclin, nitroglycerin, and effort angina. Lancet (1981) 0.79
Biomarkers of carcinogenesis in humans exposed to polycyclic aromatic hydrocarbons. Mutat Res (1999) 0.79
Detection of benzo[a]pyrene-DNA adducts in leukocytes of coke oven workers. Pathol Biol (Paris) (2000) 0.79
Ventricular arrhythmias and the autonomic tone in patients with mitral valve prolapse. Clin Cardiol (1992) 0.79
Lack of beneficial effects of L-arginine infusion in primary pulmonary hypertension. Wien Klin Wochenschr (1994) 0.78
Effects of acute euglycemic hyperinsulinemia on urinary nitrite/nitrate excretion and plasma endothelin-1 levels in men with essential hypertension and normotensive controls. Metabolism (1999) 0.78
Successful coronary stent implantation in a patient with primary antiphospholipid syndrome. Blood Coagul Fibrinolysis (1998) 0.78
The effect of verapamil on response of coronary vasomotion to handgrip exercise in symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (2001) 0.77
[Prognostic value of selected hemodynamic parameters featuring left ventricular systolic and diastolic function in patients with dilated cardiomyopathy]. Pol Arch Med Wewn (1992) 0.77
Verapamil improves the response of coronary vasomotion to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (1999) 0.77
Effect of having a functioning cadaveric renal transplant on cardiovascular mortality risk in patients on renal replacement therapy. Nephrol Dial Transplant (1995) 0.77
[Pressure increases in the left ventricle and aorta during an involuntarily induced cough reflex]. Acta Physiol Pol (1973) 0.76
[Cytoimmunologic changes in material obtained from bronchoalveolar lavage (BAL) in asymptomatic individuals chronically exposed to silica dust]. Pneumonol Alergol Pol (2000) 0.76
Impairment of coronary microvascular flow in hypertrophic cardiomyopathy. Eur Heart J (2002) 0.75
[Distribution of blood pressure in male population aged 40--59 years (author's transl)]. Przegl Lek (1975) 0.75
[The behaviour of haemodynamic indicators of pulmonary circulation and spirometric parametera under the influence of Sadamin in patients with chronic pulmonary heart syndrome]. Przegl Lek (1975) 0.75
[Volume overloading and the right-ventricular function in healthy persons and patients with primary congestive heart failure]. Folia Med Cracov (1980) 0.75
Sodium tolerance test in the detection of early stages of heart failure. Pol Med J (1972) 0.75
Coronary circulation and myocardial metabolism in dilated cardiomyopathy. Cor Vasa (1986) 0.75
The effects of regitine haemodynamics of pulmonary circulation in pulmonary hypertension in man. Acta Physiol Pol (1974) 0.75
[Phonocardiographic picture and anatomical changes in persisting ductus arteriosus]. Pol Tyg Lek (1971) 0.75
[Ultrastructural changes in the deltoid muscle (m. deltoideus) in congestive cardiomyopathy]. Patol Pol (1980) 0.75
[The hemodynamic picture of primary congestive myocardiopathy and the clinical course of the disease]. Pol Arch Med Wewn (1980) 0.75
[Effect of glucagon on the left ventricular function in patients with congestive heart failure (author's transl)]. Przegl Lek (1975) 0.75
[Results of streptokinase therapy in arterial obliterative diseases]. Kardiol Pol (1973) 0.75
[Puerperal cardiomyopathy]. Pol Tyg Lek (1974) 0.75
[Prospective studies of the respiratory system in coke plant workers]. Folia Med Cracov (1992) 0.75
Prostacyclin in the therapy of peripheral arterial disease. Adv Prostaglandin Thromboxane Res (1980) 0.75
[Hemodynamic studies in myocardial infarct]. Pol Tyg Lek (1972) 0.75
Treatment with prostacyclin of various forms of spontaneous angina pectoris not responding to placebo. Pharmacol Res Commun (1984) 0.75
[Lipoproteins (A) after a history of myocardial infarction, arteriosclerosis obliterans, hypertension and hyperlipidemia]. Kardiol Pol (1991) 0.75
[Assessment of the functional state of the liver in primary cardiomyopathy]. Pol Tyg Lek (1978) 0.75
[Myocardial blood flow in patients with mitral valve diseases]. Pol Arch Med Wewn (1974) 0.75
[Myocardial blood flow in primary congestive cardiomyopathy]. Pol Tyg Lek (1974) 0.75
[Effect of prostaglandin E1 on the left ventricle function in patients with congestive heart failure in the course of mitral valvular defects (author's transl)]. Przegl Lek (1978) 0.75
[Effect of propranolol on the electrocardiogram in Wolff-Parkinson-White disease]. Pol Tyg Lek (1971) 0.75
[Ultrastructural studies of skeletal muscles in primary congestive heart failure]. Kardiol Pol (1980) 0.75
[Electromyographic studies of skeletal muscles in patients with primary congestive cardiomyopathy]. Przegl Lek (1983) 0.75
[Effect of a methylated derivative of prostaglandin E2 (16,16-dimethyl PGE2) on the human cardiovascular system]. Pol Arch Med Wewn (1982) 0.75
Comparison of results derived from follow-up examination of respiratory systems in chosen groups of metallurgists. Pol J Occup Med Environ Health (1992) 0.75
[Clinical methods for the determination of the myocardial blood flow (author's transl)]. Przegl Lek (1973) 0.75
[Ostium secundum type of interatrial septal defect: late postoperative observation of a group of 50 patients]. Kardiol Pol (1981) 0.75
[Blood flow through the cardiac muscle and pulmonary circulation haemodynamics in patients with defects of the mitral orifice (author's transl)]. Przegl Lek (1975) 0.75
[Pulmonary hemodynamic changes following mitral commissurotomy in patients with pulmonary hypertension. Late results]. Kardiol Pol (1974) 0.75
[Value of polycardiographic records for the evaluation of pulmonary artery blood pressure. Morphological characteristics of polycardiogram in pulmonary hypertension]. Pol Tyg Lek (1970) 0.75
[Puerperal cardiomyopathy--a report of 2 cases]. Pol Tyg Lek (1974) 0.75
[Clinical studies of the hemodynamics of coronary circulation using the methods of selective administration of xenon-133 into the coronary vessels]. Kardiol Pol (1982) 0.75
[Intracardiac shunts in children, adolescents and adults (personal data)]. Kardiol Pol (1985) 0.75
Myocardial blood flow in mitral valve disease and in primary congestive cardiomyopathy, and its relation to some haemodynamic indices. Cor Vasa (1976) 0.75
[Patterns of muscle blood flow determined by means of 133 Xe in early stages of circulatory failure]. Pol Arch Med Wewn (1972) 0.75
Effect of prostaglandin E1 (PGE1) and indomethacin on pulmonary circulation in man. Acta Med Pol (1979) 0.75
[The effect of idiopathic thoracic scoliosis on the development of cor pulmonale]. Pol Tyg Lek (1970) 0.75
[Effect of volumetric overloading the left heart ventricle function in patients with primary congestive cardiomyopathy (author's transl)]. Przegl Lek (1979) 0.75
Myocardial blood flow and right coronary artery haemodynamics in patients with pulmonary hypertension. Cor Vasa (1980) 0.75
[Prostacyclin in treatment of peripheral vascular disease of lower extremities (author's transl)]. Przegl Lek (1980) 0.75
[Case of straight thoracic spine syndrome confirmed by hemodynamic studies]. Wiad Lek (1973) 0.75
[Effect of prostacycline on pulmonary circulation in pulmonary hypertension]. Kardiol Pol (1984) 0.75
Atypical funicular myuelosis diagnosed after determination of 58 Co-labeled vitamin B 12 . Pol Med Sci Hist Bull (1971) 0.75
[Effects of various meteorological factors on the incidence of myocardial infarct]. Kardiol Pol (1978) 0.75
Haemodynamic and antihypertensive effect of prostacyclin. Adv Exp Med Biol (1984) 0.75
Effect of indomethacin on pulmonary vasomotor response in patients with mitral stenosis. Eur J Cardiol (1978) 0.75
[Effect of glucagon on pulmonary hemodynamics in patients with chronic pulmonary hypertension]. Pol Arch Med Wewn (1975) 0.75
Ethanol and the function of failing left ventricle in patients with primary congestive cardiomyopathy. Acta Med Pol (1979) 0.75
[Selected clinical aspects of primary congestive cardiomyopathy basing on observation of 83 patients (author's transl)]. Przegl Lek (1981) 0.75
Hemodynamic effects of prostacyclin in man. Adv Prostaglandin Thromboxane Res (1980) 0.75
Prostacyclin for unstable angina. N Engl J Med (1980) 0.75
Plasma fibrinolytic activity in healthy subjects with high and low lipoprotein(a) concentrations. Thromb Res (1992) 0.75
[Relationship between changes in left-ventricular contraction periods caused by ethanol and the functional state of the ventricle]. Kardiol Pol (1980) 0.75
Effect of haemodynamic disturbances on the functions of the liver in chronic circulatory failure. Acta Med Pol (1980) 0.75